Skip to content

Clinical trial for Comparative Study on the Effect of Bacillus coagulans IDCC 1201 on Improvement of Sleep Health and Safety(Random Allocation, Double Blindness, Control Comparison)

Clinical trial for Comparative Study on the Effect of Bacillus coagulans IDCC 1201 on Improvement of Sleep Health and Safety(Random Allocation, Double Blindness, Control Comparison)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011568
Enrollment
80
Registered
2026-02-02
Start date
2025-02-03
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Participants will take 1 capsule (470 mg) once daily, 1 hour before bedtime, for 4 weeks (28 days). The test and control products will be manufactured to be visually and physicall

Sponsors

Ildong Bioscience
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) men and women aged 19 to 65 2) Those with a Pittsburgh Sleep Quality Index (PSQI) score of 5 or higher 3) A person who agrees to participate in this study and signs a written consent form

Exclusion criteria

Exclusion criteria: 1) Those with extreme sleep disorders (Insomnia severity index = 22 points, or = 7 points factor) 2) Those who have the following conditions (including mental illness) that cause sleep disorders : Sleep apnea (sleep apnea), restless leg syndrome, periodic limb movement disorder (periodic limb movement during sleep), depression, narcolepsy (dyspathy) 3) Changes that may cause excessive stress within 2 weeks of the first visit : : Death of spouse, family feud, litigation/dispute, sudden difficulty in living, immigration, etc 4) Those who are taking medicines that may affect their sleep within one month of their first visit 5) A person undergoing hormone therapy 6) Those who usually drink too much alcohol (>280g/week, about 5 bottles/weeks of soju) 7) Those who smoke excessively (> 10 cigarettes/day) 8) Those who consume more than 400mg of caffeine daily (ex. those who consume 8 cups of mixed coffee, 3 cups of americano, and 8 cups of green tea or more) 9) A night shift worker or a person whose bedtime is irregular due to his/her usual job, etc 10) A person who has traveled long distances to a country with a different time difference within one month of his/her first visit 11) Body mass index (BMI) is 18kg/m2 or less or 35kg/m2 or more 12) A person who has continuously consumed health functional food or herbal medicine within one month of his/her first visit 13) A person who participated in a clinical trial within one month of the first visit 14) Pregnant women and nursing mothers 15) If the researcher deems it inappropriate to participate in this test

Design outcomes

Primary

MeasureTime frame
Sleep efficiency (SE);sleep incubation period (SL);total sleep time (TST);wake-up time (WASO);Delta power;Pittsburgh sleep quality assessment questionnaire (PSQI)

Secondary

MeasureTime frame
Stanford Sleepiness Scale (SSS) questionnaire;daytime sleepiness scale (ESS) questionnaire;Insomnia Severity Index (ISI) questionnaire;Korean version of the Perceived Stress Scale (PSS);weekly Resilient Sleep Score (RSQ-W) questionnaire;Blood GABA level

Countries

Korea, Republic of

Contacts

Public ContactMUN HYUK SEONG

Seroul Health Care

netseong@daum.net+82-2-780-0151

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 15, 2026